Barriers to receipt of prenatal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine among mothers of infants aged <4 months with pertussis — California, 2016

Sarah New, Kathleen Winter, Rebeca Boyte, Kathleen Harriman, Anya Gutman, Amber Christiansen, Sarah Royce

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

What is already known about this topic? Although tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination is recommended for all pregnant women during 27-36 weeks’ gestation to prevent infant pertussis, coverage among pregnant women is suboptimal. What is added by this report? Among 66 interviewed mothers of infants aged <4 months with pertussis, 30% appropriately received Tdap vaccine. Women whose clinics stocked Tdap vaccine were more likely to be vaccinated. Women with Medicaid were less likely to be vaccinated than were those with private insurance, even when treated in clinics that stocked Tdap vaccine. What are the implications for public health practice? Promoting on-site prenatal vaccination, educating providers about Tdap recommendations, and strengthening off-site referral likely will improve Tdap vaccination coverage during pregnancy.

Original languageEnglish
Pages (from-to)1068-1071
Number of pages4
JournalMorbidity and Mortality Weekly Report
Volume67
Issue number38
DOIs
StatePublished - Sep 28 2018

Bibliographical note

Publisher Copyright:
© 2018, Department of Health and Human Services. All Rights Reserved.

ASJC Scopus subject areas

  • Epidemiology
  • Health(social science)
  • Health, Toxicology and Mutagenesis
  • Health Information Management

Fingerprint

Dive into the research topics of 'Barriers to receipt of prenatal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine among mothers of infants aged <4 months with pertussis — California, 2016'. Together they form a unique fingerprint.

Cite this